AI assistant
Solid Biosciences Inc. — Director's Dealing 2024
Feb 16, 2024
33003_dirs_2024-02-16_30e927ef-912a-435e-980b-a2db9915146c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2024-02-13
Reporting Person: Howton David T (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-13 | Employee Stock Option (Right to Buy) | $7.85 | A | 117500 | Acquired | 2034-02-13 | Common Stock (117500) | Direct |
| 2024-02-13 | Restricted Stock Units | $ | A | 58750 | Acquired | Common Stock (58750) | Direct |
Footnotes
F1: This option was granted on February 13, 2024 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.
F2: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").
F3: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.